Hyperlipidemia
📧 Sign up to get email alerts when something new happens for Hyperlipidemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-10-29Clinical Trial Update: European Study of Cardiovascular Risk
A European cardiovascular risk trial sponsored by AstraZeneca has completed, focusing on cardiovascular risk factors and hyperlipidemia.
-
FDA approval · 2009-10-02FDA Approved: WELCHOL — Original Application (Cosette Pharmaceuticals, Inc.)
FDA approved Cosette Pharmaceuticals' original NDA for Welchol (colesevelam hydrochloride). Welchol is a bile acid sequestrant used to treat…
-
CLINICAL_TRIALS research · 2009-09-10Clinical Trial Update: Pitavastatin on Carotid Intima-media Thickness [NA]
Clinical trial evaluating the effect of pitavastatin on carotid intima-media thickness in patients with hyperlipidemia and carotid artery di…
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Awareness of Chinese National Adult Lipid Treatment Guideline (2007) and Rate of Patients Achieving the Treatment Goal
This clinical trial update reports on awareness of the 2007 Chinese National Lipid Treatment Guideline and the proportion of patients achiev…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: A Randomized Controlled Trial of a Novel Community-based Primary and Secondary Cardiovascular Prevention Program [NA]
A randomized controlled trial evaluating a community-based cardiovascular prevention program has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-08-03FDA Approved: LIVALO — Original Application (Kowa Pharmaceuticals America, Inc.)
FDA approved LIVALO (pitavastatin calcium) from Kowa Pharmaceuticals America, Inc. as an original NDA (NDA022363) for the treatment of hyper…
-
CLINICAL_TRIALS trial_result · 2009-08-03Clinical Trial Update: To Evaluate Ezetimibe/Simvastatin and Niacin (Extended Release Tablet) in Patients With Type IIa or Type IIb Hyperlipidemia (0653A-091)(COMPLETED) [Phase 3]
A Phase 3 trial assessed the lipid-lowering effects of combining ezetimibe/simvastatin with extended-release niacin in patients with Type II…
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention [Phase 1, Phase 2]
A Phase 1/2 clinical trial update examining cholesterol and fatty acid synthesis in islet and liver transplant patients and the impact of a …
-
FDA approval · 2009-07-21FDA Approved: ZETIA — Supplemental Application (Organon LLC)
The FDA approved a supplemental application for Zetia (ezetimibe) submitted by Organon LLC.
-
FDA approval · 2009-07-20FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application from Prasco Laboratories for the fixed-dose combination of amlodipine and atorvastatin (amlodipi…
-
FDA approval · 2009-07-14FDA Approved: LOPID — Supplemental Application (Parke-Davis Div of Pfizer Inc)
The FDA approved a supplemental application for Lopid (gemfibrozil) filed by the Parke-Davis division of Pfizer Inc. The action updates the …
-
CLINICAL_TRIALS trial_result · 2009-07-14Clinical Trial Update: Efficacy of Exercise at a Fitness Club for Cardiovascular Risk Reduction [Phase 1, Phase 2]
This completed Phase 1/2 trial evaluated the efficacy of a fitness-club–based exercise program for reducing cardiovascular risk in adults wi…
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Comparison of the Combination of Fenofibrate and Simvastatin Versus Atorvastatin [Phase 3]
A Phase 3 clinical trial comparing the combination of fenofibrate and simvastatin versus atorvastatin for hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin [Phase 3]
A Phase 3 trial comparing the combination of fenofibrate and simvastatin against pravastatin for hyperlipidemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-08Clinical Trial Update: Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin Monotherapy [Phase 3]
Phase 3 trial comparing the combination of fenofibrate with simvastatin 20 mg versus simvastatin 40 mg monotherapy in hyperlipidemia. The st…
-
CLINICAL_TRIALS research · 2009-06-26Clinical Trial Update: Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes [NA]
This clinical trial investigates how dietary supplementation with plant sterol esters affects human monocytes in individuals with hyperlipid…
-
CLINICAL_TRIALS trial_result · 2009-06-23Clinical Trial Update: Phase II Study of Heart Polypill Safety and Efficacy in Primary Prevention of Cardiovascular Disease [Phase 2]
Phase II trial results evaluating the safety and efficacy of a Heart Polypill for primary prevention of cardiovascular disease have been pos…
-
CLINICAL_TRIALS trial_result · 2009-06-17Clinical Trial Update: Effects of Colesevelam HCl, Rosiglitazone, Sitagliptin on Control of Blood Glucose and Lipids in Type 2 Diabetes Patients Whose Blood Glucose Isn't Completely Controlled With Metformin [Phase 3]
Phase 3 trial update evaluating the effects of adding colesevelam HCl, rosiglitazone, and sitagliptin to metformin in adults with type 2 dia…
-
CLINICAL_TRIALS trial_result · 2009-05-21Clinical Trial Update: The Efficacy of Red Grape Seed Extract on Lipid Profile and Oxidized Low-Density Lipoprotein (OX-LDL) [Phase 2, Phase 3]
Phase 2 and Phase 3 trials assessed red grape seed extract for effects on lipid profiles and oxidized LDL in hyperlipidemia; the study is re…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: Effect of MK0524A on Cholesterol Levels (0524A-048) [Phase 3]
Phase 3 clinical trial evaluating MK0524A's effect on cholesterol levels in patients with hypercholesterolemia and hyperlipidemia; the study…
-
CLINICAL_TRIALS trial_result · 2009-05-13Clinical Trial Update: An Open-Label Study to Compare the Lipid Effects of Niacin ER and Simvastatin (NS) to Atorvastatin in Subjects With Hyperlipidemia or Mixed Dyslipidemia (SUPREME) [Phase 3]
This completed Phase 3 open-label trial evaluated lipid-lowering effects of Niacin ER combined with Simvastatin versus Atorvastatin in adult…
-
CLINICAL_TRIALS trial_result · 2009-04-14Clinical Trial Update: Peripheral Effects of Exercise on Cardiovascular Health (STRRIDE I) [Phase 2]
Phase 2 clinical trial STRRIDE I evaluating peripheral effects of exercise on cardiovascular health has completed.
-
CLINICAL_TRIALS trial_result · 2009-04-08Clinical Trial Update: The Influence of Soy Isoflavnoids on the Hypocholesterolemic Effects of Soy [Phase 2]
A Phase 2 trial evaluating whether soy isoflavonoids influence the cholesterol-lowering effects of soy in individuals with hyperlipidemia or…
-
FDA approval · 2009-04-03FDA Approved: SIMVASTATIN — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for simvastatin from NorthStar Rx LLC under ANDA 077691, granting approval for a change to the gener…
-
FDA approval · 2009-03-27FDA Approved: LIPITOR — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Lipitor (atorvastatin calcium) submitted by Viatris Specialty LLC.